Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New factor Xa inhibitors designed at DuPont Merck

April 8, 1998

RPR-130737, a potent nonpeptidyl inhibitor of factor Xa

April 7, 1998

Merck & Co. designates thrombin inhibitor for clinical development

April 7, 1998

Early clinical trial evaluates orbofiban pharmacodynamics

April 7, 1998

FDA advisory committee will discuss Aggrastat NDA later this week

April 7, 1998

FDA approves another new indication for Lovenox

April 7, 1998

Antiplatelet and antithrombotic effects of FR-171113 in guinea pigs

April 6, 1998

Orally active thrombin inhibitor discovered at Pfizer shows good tolerance in phase I

April 6, 1998

Amidino derivatives for thrombosis reported by Astra

April 6, 1998

ART-123, a human recombinant thrombomodulin, demonstrates acceptable safety profile

April 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...